《中国糖尿病杂志》官方网站

20

您的位置:首页 > 中国糖尿病杂志 > 2014年 > 10期

二肽基肽酶4抑制剂沙格列汀改善过氧化氢诱导损伤的血管内皮细胞一氧化氮和内皮素1的分泌异常

来自:中国糖尿病杂志  编辑:韩白玉 卢岚敏 张丽萍 范忠义|点击数:|2014-10-21

 ·糖尿病基础研究·

  【摘要】 目的 观察二肽基肽酶-4(DPP-4)抑制剂沙格列汀对过氧化氢(H2O2)诱导损伤的血管内皮细胞分泌一氧化氮(NO)及内皮素-1(ET-1)的影响。 方法 以培养人脐静脉内皮细胞株(HUVEC)作为靶细胞,在内皮细胞培养基中加入100 µmol/L H2O2制备细胞损伤模型,以不同浓度沙格列汀(5、10、20、40 µmol/L)进行干预,观察不同培养时间(0、12、24、36 h)各浓度组的差异。分别采用硝酸还原酶法和放射免疫法法检测细胞上清液中NO及ET-1含量。 结果 H2O2作用HUVEC后,细胞上清NO含量降低,而ET-1含量升高(P<0.05)。各浓度沙格列汀组NO含量均高于模型组(100 µmol/L H2O2),而ET-1含量降低,这种作用在一定剂量范围内随药物剂量增加而增强,在一定时间范围内随时间增加而增强(P<0.05)。 结论 沙格列汀可改善H2O2引起的血管内皮细胞NO、ET-1分泌异常。

  【关键词】 沙格列汀;血管内皮细胞;一氧化氮;内皮素

  【Abstract】 Objective To investigate the effect of DPP-4 inhibitor saxagliptin on the release of nitric oxide (NO) and endothelin-1 (ET-1) secreted by injured human umbilical vein endothelial cells (HUVECs) induced by H2O2. Methods HUVECs were cultivated in culture medium containing 100 µmol/L H2O2 to established cell injury model. Various doses of saxagliptin (5、10、20、40 µmol/L)were applied to intervention. The concentration of NO and ET-1 in the supernatant of HUVECs was detected respectively at different time points(0、12、24、36 h). Result The concentration of NO was decreased and the secretion of ET-1 was increased induced by H2O2(P<0.05). The concentration of NO were higher in all groups with different concentration of saxagliptin than in model group(100 µmol/L H2O2), but the concentration of ET-1 were not(P<0.05). Moreover, the improvment of saxagliptin was dose-dependent and time-dependent within a certain dose range and a certain time range (P<0.05). Conclusion Saxagliptin could improve the abnormal release of NO and ET-1 induced by HUVECs.

  【Key words】 Saxagliptin; Human umbilical vein endothelial cells; Nitric Oxide; Endothelin-1

上一篇: 玉葵清对糖基化终产物诱导的人肾系膜细胞趋化因子表达的影响 下一篇: 长期口服吲达帕胺诱发糖尿病1例报道